| Ms Aneesah Friday, | |
|
1500 Saint Georges Ave Ste E, Avenel, NJ 07001-1000 | |
| (856) 772-5809 | |
| (856) 772-5852 |
| Full Name | Ms Aneesah Friday |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 1500 Saint Georges Ave Ste E, Avenel, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245923903 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Aneesah Friday, 1500 Saint Georges Ave Ste E, Avenel, NJ 07001-1000 Ph: (856) 772-5809 | Ms Aneesah Friday, 1500 Saint Georges Ave Ste E, Avenel, NJ 07001-1000 Ph: (856) 772-5809 |
News Archive
Scientists have discovered that a deadly parasite, known to cause ill health in pregnant women and immunocompromised patients, could potentially be used to treat various types of tumors.
While several COVID-19 vaccine candidates have been developed and deployed to arrest the spread of SARS-CoV-2, concern among scientists and public health authorities is mounting over the immunity escape potential of emerging viral variants. To address this problem, a group of scientists in Germany has undertaken research to identify molecular targets across viral variants to aid in the development of second and third-generation vaccines and novel therapeutics.
The compulsory use of vaccines to prevent the effects of a bioterrorist attack seems to be based on an unproved threat, according to an editorial in this week's BMJ.
​Researchers from Columbia University Medical Center (CUMC) have found that the skeleton, acting through the bone-derived hormone osteocalcin, exerts a powerful influence on prenatal brain development and cognitive functions such as learning, memory, anxiety, and depression in adult mice.
Civitas Therapeutics, Inc., a privately-held pharmaceutical company developing transformative therapeutics using the ARCUS respiratory delivery platform, announced today the initiation of a Phase 2a clinical trial in Parkinson's disease patients evaluating CVT-301, an inhaled formulation of levodopa (L-dopa), for the rapid relief from motor fluctuations.
› Verified 7 days ago
Leila Hodzic, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 8 Production Way, Avenel, NJ 07001 Phone: 609-276-2052 | |
Corina Harten, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 36 Westside Ave, Avenel, NJ 07001 Phone: 732-726-9624 | |
Tia Babb, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1500 Saint Georges Ave Ste E, Avenel, NJ 07001 Phone: 856-772-5800 | |
Kathleen C. Win, MSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 239 Avenel St, Suite 11, Avenel, NJ 07001 Phone: 908-412-6206 Fax: 908-412-6206 | |
Aliza Auslander, LSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 8 Production Way, Avenel, NJ 07001 Phone: 732-699-8036 | |
Michelle Paxton, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1500 Saint Georges Ave Ste E, Avenel, NJ 07001 Phone: 856-772-5809 |